A phospholipid complex to improve the oral bioavailability of flavonoids

References

• Zhu F, Huang B, Hu CY, et al. Effects of total flavonoids of Hippophae rhamnoides L. on intracellular free calcium in cultured vascular smooth muscle cells of spontaneously hypertensive rats and Wistar-Kyoto rats. Chin J Integr Med 2005;11:287–92
   PubMedGoogle Scholar
• Geetha S, Sai Ram M, Singh V, et al. Anti-oxidant and immunomodulatory properties of seabuckthorn (Hippophae rhamnoides) – an in vitro study. J Ethnopharmacol 2002;79:373–8
   PubMed Web of Science ®Google Scholar
• Yogendra Kumar MS, Tirpude RJ, Maheshwari DT, et al. Antioxidant and antimicrobial properties of phenolic rich fraction of Seabuckthorn (Hippophae rhamnoides L.) leaves in vitro. Food Chem 2013;141:3443–50
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang W, Zhu D, et al. Hypolipidaemic and hypoglycaemic effects of total flavonoids from seed residues of Hippophae rhamnoides L. in mice fed a high-fat diet. J Sci Food Agric 2011;91:1446–51
   PubMed Web of Science ®Google Scholar
• Maheshwari DT, Yogendra Kumar MS, Verma SK, et al. Antioxidant and hepatoprotective activities of phenolic rich fraction of Seabuckthorn (Hippophae rhamnoides L.) leaves. Food Chem Toxicol 2011;49:2422–8
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang Y, Wang B, et al. Effects of total flavones of fructus Hippophae (TFH) on cardiac function and hemodynamics of anesthetized open-chest dogs with acute heart failure. Zhongguo Zhong yao za zhi 1997;22:429–31, 448
   PubMedGoogle Scholar
• Cheng J, Kondo K, Suzuki Y, et al. Inhibitory effects of total flavones of Hippophae Rhamnoides L on thrombosis in mouse femoral artery and in vitro platelet aggregation. Life Sci 2003;72:2263–71
   PubMed Web of Science ®Google Scholar
• Zhao G, Duan J, Xie Y, et al. Effects of solid dispersion and self-emulsifying formulations on the solubility, dissolution, permeability and pharmacokinetics of isorhamnetin, quercetin and kaempferol in total flavones of Hippophae rhamnoides L. Drug Dev Ind Pharm 2013;39:1037–45
   PubMed Web of Science ®Google Scholar
• Barve A, Chen C, Hebbar V, et al. Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats. Biopharm Drug Dispos 2009;30:356–65
   PubMed Web of Science ®Google Scholar
• Khaled KA, El-Sayed YM, Al-Hadiya BM. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Drug Dev Ind Pharm 2003;29:397–403
   PubMed Web of Science ®Google Scholar
• Rabinovich-Guilatt L, Dubernet C, Gaudin K, et al. Phospholipid hydrolysis in a pharmaceutical emulsion assessed by physicochemical parameters and a new analytical method. Eur J Pharm Biopharm 2005;61:69–76
   PubMed Web of Science ®Google Scholar
• Rao SV, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int J Pharm 2008;362:2–9
   PubMed Web of Science ®Google Scholar
• Henmi T, Fujii M, Kikuchi K, et al. Application of an oily gel formed by hydrogenated soybean phospholipids as a percutaneous absorption-type ointment base. Chem Pharm Bull (Tokyo) 1994;42:651–5
   PubMed Web of Science ®Google Scholar
• Sha XY, Guo J, Chen YZ, Fang XL. Effect of phospholipid composition on pharmacokinetics and biodistribution of epirubicin liposomes. J Liposome Res 2012;22:80–8
   PubMed Web of Science ®Google Scholar
• Garcia-Moreno PJ, Frisenfeldt Horn A, Jacobsen C. Influence of casein–phospholipid combinations as emulsifier on the physical and oxidative stability of fish oil-in-water emulsions. J Agric Food Chem 2014;62:1142–52
   PubMed Web of Science ®Google Scholar
• Yue PF, Yuan HL, Xie H, et al. Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex in vivo. Drug Dev Ind Pharm 2008;34:708–18
   PubMed Web of Science ®Google Scholar
• Yue PF, Yuan HL, Li XY, et al. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Int J Pharm 2010;387:139–46
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Ahmmed SM, Saha BP, Mukherjee PK. Soya phospholipid complex of mangiferin enhances its hepatoprotectivity by improving its bioavailability and pharmacokinetics. J Sci Food Agric 2013;94:1380–8
   PubMed Web of Science ®Google Scholar
• Yue PF, Zhang WJ, Yuan HL, et al. Process optimization, characterization and pharmacokinetic evaluation in rats of ursodeoxycholic acid–phospholipid complex. AAPS PharmSciTech 2008;9:322–9
   PubMed Web of Science ®Google Scholar
• Xiao YY, Song YM, Chen ZP, Ping QN. Preparation of silybin–phospholipid complex and its bioavailability in rats. Yao Xue Xue Bao 2005;40:611–17
   PubMedGoogle Scholar
• Maiti K, Mukherjee K, Gantait A, et al. Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J Pharm Pharmacol 2006;58:1227–33
   PubMed Web of Science ®Google Scholar
• Zhang Z, Huang Y, Gao F, et al. Daidzein–phospholipid complex loaded lipid nanocarriers improved oral absorption: in vitro characteristics and in vivo behavior in rats. Nanoscale 2011;3:1780–7
   PubMed Web of Science ®Google Scholar
• Chen ZP, Sun J, Chen HX, et al. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats. Fitoterapia 2010;81:1045–52
   PubMed Web of Science ®Google Scholar
• Tedesco D, Steidler S, Galletti S, et al. Efficacy of silymarin–phospholipid complex in reducing the toxicity of aflatoxin B1 in broiler chicks. Poult Sci 2004;83:1839–43
   PubMed Web of Science ®Google Scholar
• Li Y, Pan WS, Chen SL, et al. Studies on preparation of puerarin phytosomes and their solid dispersion. Chin Pharm J 2006;41:1162–7
   Google Scholar
• Li GW, Zeng XL, Xie Y, et al. Pharmacokinetic properties of isorhamnetin, kaempferol and quercetin after oral gavage of total flavones of Hippophae rhamnoides L. in rats using a UPLC-MS method. Fitoterapia 2012;83:182–91
   PubMed Web of Science ®Google Scholar
• Zhang J, Peng Q, Shi S, et al. Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin–phospholipid complex. Int J Nanomed 2011;6:3405–14
   PubMed Web of Science ®Google Scholar
• Li Y, Yang DJ, Chen SL, et al. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. Pharm Res 2008;25:563–77
   PubMed Web of Science ®Google Scholar
• Sikarwar MS, Sharma S, Jain AK, Parial SD. Preparation, characterization and evaluation of marsupsin–phospholipid complex. AAPS PharmSciTech 2008;9:129–37
   PubMed Web of Science ®Google Scholar
• Shi K, Cui FD, Yu YW, et al. Preparation and characterization of a novel insulin–phospholipid complex. Asian J Pharm Sci 2006;1:168–74
   Google Scholar
• Yanyu X, Yunmei S, Zhipeng C, Qineng P. The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 2006;307:77–82
   PubMed Web of Science ®Google Scholar
• Singh C, Bhatt TD, Gill MS, Suresh S. Novel rifampicin–phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation. Int J Pharm 2014;460:220–7
   PubMed Web of Science ®Google Scholar
• Singh D, Rawat MSM, Semalty A, Semalty M. Rutin–phospholipid complex: an innovative technique in novel drug delivery system – NDDS. Curr Drug Deliv 2012;9:305–14
   PubMed Web of Science ®Google Scholar
• Rawat DS, Thakur BK, Semalty M, et al. Baicalein–phospholipid complex: a novel drug delivery technology for phytotherapeutics. Curr Drug Discov Technol 2013;10:224–32
   PubMedGoogle Scholar
• Korinth G, Wellner T, Schaller KH, Drexler H. Potential of the octanol–water partition coefficient (logP) to predict the dermal penetration behaviour of amphiphilic compounds in aqueous solutions. Toxicol Lett 2012;215:49–53
   PubMed Web of Science ®Google Scholar
• Singh D, Rawat MSM, Semalty A, Semalty M. Chrysophanol–phospholipid complex A drug delivery strategy in herbal novel drug delivery system (HNDDS). J Therm Anal Calorim 2013;111:2069–77
   Web of Science ®Google Scholar
• Tan Q, Liu S, Chen X, et al. Design and evaluation of a novel evodiamine–phospholipid complex for improved oral bioavailability. AAPS PharmSciTech 2012;13:534–47
   PubMed Web of Science ®Google Scholar
• Husch J, Dutagaci B, Glaubitz C, et al. Structural properties of so-called NSAID–phospholipid-complexes. Eur J Pharm Sci 2011;44:103–16
   PubMed Web of Science ®Google Scholar
• DuPont MS, Day AJ, Bennett RN, et al. Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. Eur J Clin Nutr 2004;58:947–54
   PubMed Web of Science ®Google Scholar
• Schulz HU, Schurer M, Bassler D, Weiser D. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet. Arzneim-Forsch 2005;55:15–22
   PubMed Web of Science ®Google Scholar
• Lin JH. Species similarities and differences in pharmacokinetics. Drug Metab Dispos 1995;23:1008–21
   PubMed Web of Science ®Google Scholar
• Walgren RA, Karnaky KJ Jr, Lindenmayer GE, Walle T. Efflux of dietary flavonoid quercetin 4′-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther 2000;294:830–6
   PubMed Web of Science ®Google Scholar
• Pal D, Mitra AK. MDR- and CYP3A4-mediated drug–herbal interactions. Life Sci 2006;78:2131–45
   PubMed Web of Science ®Google Scholar
• Wang Y, Cao J, Zeng S. Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin. J Pharm Pharmacol 2005;57:751–8
   PubMed Web of Science ®Google Scholar
• Limtrakul P, Khantamat O, Pintha K. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J Chemother 2005;17:86–95
   PubMed Web of Science ®Google Scholar
• Chang TK, Chen J, Yeung EY. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1. Toxicol Appl Pharmacol 2006;213:18–26
   PubMed Web of Science ®Google Scholar
• Chang Q, Zuo Z, Ho WK, Chow MS. Comparison of the pharmacokinetics of hawthorn phenolics in extract versus individual pure compound. J Clin Pharmacol 2005;45:106–12
   PubMed Web of Science ®Google Scholar